GENERAL ATLANTIC, L.P. Diversified Active

Location: New York, NY

CIK: 0001017645 · Show all filings

Period: Q4 2024 (← Previous) (Next →)

Filing Date: Feb 7, 2025

Total Value: $2.809B (100.0% shares, 0.0% debt)

Holdings (16)

DLO DLOCAL 25.6%

Value $720M Shares 63,906,695 Est. Cost — Unrealized —

ALHC ALIGNMENT HEALTHCARE 24.4%

Value $686M Shares 60,993,323 Est. Cost — Unrealized —

ALKT ALKAMI 12.6%

Value $354M Shares 9,645,318 Est. Cost — Unrealized —

XP XP, INC 12.5%

Value $351M Shares 29,617,733 Est. Cost — Unrealized —

CNTA CENTESSA PHARMACEUTICALS 5.8%

Value $162M Shares 9,681,818 Est. Cost — Unrealized —

— AKERO THERAPEUTICS 5.2%

Value $146M Shares 5,233,989 Est. Cost — Unrealized —

PHVS PHARVARIS 5.1%

Value $144M Shares 7,531,252 Est. Cost — Unrealized —

EWCZ EUROPEAN WAX CENTER 3.1%

Value $87.45M Shares 13,110,492 Est. Cost — Unrealized —

RPRX ROYALTY PHARMA 1.4%

Value $38.27M Shares 1,500,000 Est. Cost — Unrealized —

IMCR IMMUNOCORE 1.3%

Value $37.22M Shares 1,261,684 Est. Cost — Unrealized —

— THIRD HARMONIC BIO 1.2%

Value $34.7M Shares 3,372,323 Est. Cost — Unrealized —

RSKD RISKIFIED 0.9%

Value $25.19M Shares 5,324,998 Est. Cost — Unrealized —

— ACELYRIN 0.3%

Value $8.463M Shares 2,695,327 Est. Cost — Unrealized —

ADAG ADAGENE 0.3%

Value $7.614M Shares 3,825,952 Est. Cost — Unrealized —

Value $4.286M Shares 609,616 Est. Cost — Unrealized —

GROV GROVE COLLABORATIVE 0.1%

Value $3.44M Shares 2,474,859 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DLO	DLOCAL	63,906,695	$720M	25.6%	—	—	CL A	G29018101
ALHC	ALIGNMENT HEALTHCARE	60,993,323	$686M	24.4%	—	—	COM	01625V104
ALKT	ALKAMI	9,645,318	$354M	12.6%	—	—	COM	01644J108
XP	XP, INC	29,617,733	$351M	12.5%	—	—	CL A	G98239109
CNTA	CENTESSA PHARMACEUTICALS	9,681,818	$162M	5.8%	—	—	ADS	152309100
—	AKERO THERAPEUTICS	5,233,989	$146M	5.2%	—	—	COM	00973Y108
PHVS	PHARVARIS	7,531,252	$144M	5.1%	—	—	COM	N69605108
EWCZ	EUROPEAN WAX CENTER	13,110,492	$87.45M	3.1%	—	—	CL A	29882P106
RPRX	ROYALTY PHARMA	1,500,000	$38.27M	1.4%	—	—	CL A	G7709Q104
IMCR	IMMUNOCORE	1,261,684	$37.22M	1.3%	—	—	ADS	45258D105
—	THIRD HARMONIC BIO	3,372,323	$34.7M	1.2%	—	—	COM	88427A107
RSKD	RISKIFIED	5,324,998	$25.19M	0.9%	—	—	CL A	M8216R109
—	ACELYRIN	2,695,327	$8.463M	0.3%	—	—	COM	00445A100
ADAG	ADAGENE	3,825,952	$7.614M	0.3%	—	—	ADS	005329107
—	WISH	609,616	$4.286M	0.2%	—	—	CL A	21077C305
GROV	GROVE COLLABORATIVE	2,474,859	$3.44M	0.1%	—	—	CL A	39957D201